Evaluating Helicobacter pylori Infection as a Risk Factor for Iron Deficiency Anemia: A Case-Control Approach
Dipendra Singh1, Varun Upadhyay2, Sunny Bhushan Singh2
1Orthopedics, Soo-Jung Hospital Doti, Rajpur Doti, NPL.
Helicobacter pylori infection is strongly linked to iron deficiency anemia (IDA). Eradicating H. pylori may help manage and resolve IDA, especially in patients with poor nutrition or NSAID use.
Area of Science:
- Medical Science
- Gastroenterology
- Hematology
Background:
- Helicobacter pylori infection is increasingly recognized as a cause of extra-gastrointestinal issues, notably iron deficiency anemia (IDA).
- Understanding the relationship between H. pylori and IDA is crucial for effective patient management.
Purpose of the Study:
- To investigate the association between Helicobacter pylori infection and iron deficiency anemia using a case-control study.
- To analyze the prevalence of H. pylori in patients with IDA compared to healthy controls.
Main Methods:
- A case-control study involving 48 participants (24 IDA cases, 24 controls) matched for age and sex.
- H. pylori infection assessed via stool antigen or urea breath tests; data on diet, NSAID use, and symptoms collected.
- Statistical analysis using independent t-tests and chi-square tests (p < 0.05 significance).
Main Results:
- H. pylori positivity was significantly higher in IDA patients (87.5%) versus controls (29.2%) (p < 0.001).
- IDA cases showed lower hemoglobin, ferritin, and serum iron levels, with elevated total iron-binding capacity.
- Poor nutritional status and NSAID use were more common in H. pylori-positive individuals.
Conclusions:
- H. pylori infection is directly implicated in the development of iron deficiency anemia.
- Combined assessment and treatment of H. pylori infection show promise for managing IDA, particularly in at-risk populations.
More Related Videos
03:47Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
Published on: November 1, 2024
03:33Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
Published on: May 23, 2025
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
